Chemopreventative Effects Of Protandim® Examined Further In New Peer-Reviewed Study

LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE…

share save 171 16 Chemopreventative Effects Of Protandim® Examined Further In New Peer Reviewed Study

Leave a Reply